author-photo

Yu Kuramochi

2

Papers

39

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

2017 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (38)
First-in-human phase I administration of YS110, a monoclonal antibody directed against the CD26 immunostimulatory molecule in advanced cancer patients.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)